Pasar al contenido principal

KLOTHO, INFLAMACION Y DISFUNCION DEL INJERTO RENAL: ESTUDIO PROSPECTIVO DE COHORTES EN PACIENTES CON TRASPLANTE RENAL

PI17/02043

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD (FIMABIS)
Centro realización INSTITUTO DE INVESTIGACION BIOMEDICA DE MALAGA (IBIMA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal

  • López, V.
  • Vázquez, T.
  • Alonso-Titos, J.
  • Cabello, M.
  • Alonso, A.
  • Beneyto, I.
  • Crespo, M.
  • Díaz-Corte, C.
  • Franco, A.
  • González-Roncero, F.
  • Gutiérrez, E.
  • Guirado, L.
  • Jiménez, C.
  • Jironda, C.
  • Lauzurica, R.
  • Llorente, S.
  • Mazuecos, A.
  • Paul, J.
  • Rodríguez-Benot, A.
  • Ruiz, J.C.
  • Sánchez-Fructuoso, A.
  • Sola, E.
  • Torregrosa, V.
  • Zárraga, S.
  • Hernández, D.
  • Grupo de Estudio GREAT (Grupo Español de Actualizaciones en Trasplante)
La pandemia por coronavirus SARS-CoV-2 (Covid-19) está evolucionando de manera muy rápida y representa un riesgo especial en pacientes inmunodeprimidos y con comorbilidades añadidas. El conocimiento sobre esta infección emergente va también en aumento, si bien, aún sigue habiendo muchas incógnitas, sobre todo en la población con trasplante renal. Este manuscrito presenta una propuesta de actuación con recomendaciones generales y específicas para proteger y prevenir de la infección a esta población tan vulnerable como son los receptores de un trasplante renal.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients

  • Hernández, Domingo
  • Vázquez, Teresa
  • Alonso-Titos, Juana
  • León, Myriam
  • Caballero, Abelardo
  • Cobo, María Angeles
  • Sola, Eugenia|||0000-0002-9462-3342
  • López Jiménez, Verónica|||0000-0002-1793-7065
  • Ruiz-Esteban, Pedro
  • Cruzado, Josep María
  • Sellarés, Joana
  • Moreso, Francesc|||0000-0002-7267-3963
  • Manonelles, Anna|||0000-0003-2456-388X
  • Torio, Alberto
  • Cabello, Mercedes
  • Delgado-Burgos, Juan
  • Casas, Cristina
  • Gutiérrez, Elena
  • Jironda, Cristina
  • Kanter, Julia
  • Seron, Daniel|||0000-0003-2054-653X
  • Torres, Armando|||0000-0003-1121-5173
The impact of human leukocyte antigen (HLA)-mismatching on the early appearance of subclinical inflammation (SCI) in low-immunological-risk kidney transplant (KT) recipients is undetermined. We aimed to assess whether HLA-mismatching (A-B-C-DR-DQ) is a risk factor for early SCI. As part of a clinical trial (Clinicaltrials.gov, number NCT02284464), a total of 105 low-immunological-risk KT patients underwent a protocol biopsy on the third month post-KT. As a result, 54 presented SCI, showing a greater number of total HLA-mismatches (p = 0.008) and worse allograft function compared with the no inflammation group (48.5 ± 13.6 vs. 60 ± 23.4 mL/min; p = 0.003). Multiple logistic regression showed that the only risk factor associated with SCI was the total HLA-mismatch score (OR 1.32, 95%CI 1.06-1.64, p = 0.013) or class II HLA mismatching (OR 1.51; 95%CI 1.04-2.19, p = 0.032) after adjusting for confounder variables (recipient age, delayed graft function, transfusion prior KT, and tacrolimus levels). The ROC curve illustrated that the HLA mismatching of six antigens was the optimal value in terms of sensitivity and specificity for predicting the SCI. Finally, a significantly higher proportion of SCI was seen in patients with.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recommendations for living donor kidney transplantation Recomendaciones para el trasplante renal de donante vivo

  • Frutos, Migeul Ángel
  • Crespo, Marta|||0000-0001-6992-6379
  • Valentín, María de la Oliva
  • Alonso-Melgar, Ángel
  • Alonso, Juana
  • Fernández, Constantino
  • García-Erauzkin, Gorka
  • González, Esther
  • González-Rinne, Ana M.
  • Guirado, Luis|||0000-0001-5119-3912
  • Gutiérrez Dalmau, Álex
  • Huguet Perez, Jordi
  • López del Moral, José Luis
  • Musquera, Mireia
  • Paredes, David
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Revuelta, Ignacio|||0000-0002-3584-4516
  • Van-der Hofstadt, Carlos J.
  • Alcaraz, Antonio|||0000-0003-2612-5250
  • Alonso-Hernández, Ángel
  • Alonso, Manuel
  • Bernabeu, Purificación
  • Bernal Blanco, Gabriel
  • Breda, Alberto|||0000-0002-7842-9048
  • Cabello, Mercedes
  • Caro-Oleas, José Luis
  • Cid, Joan|||0000-0001-5445-4508
  • Diekmann, Fritz|||0000-0001-6199-3016
  • Espinosa, Laura
  • Facundo, Carme|||0000-0003-1254-5553
  • García, Marta|||0000-0001-5155-4730
  • Gil-Vernet, Salvador
  • Lozano, Miquel|||0000-0003-2593-833X
  • Mahillo, Beatriz
  • Martínez, María José
  • Miranda Serrano, Blanca
  • Oppenheimer, Federico|||0000-0002-1117-831X
  • Palou, Eduard|||0000-0003-1544-1485
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Peri, Lluis
  • Rodríguez Faba, Óscar|||0000-0001-6668-4423
  • Santiago, Carlos
  • Tabernero, Guadalupe
  • Hernández, Domingo
  • Domínguez-Gil, Beatriz|||0000-0002-5695-8993
  • Pascual, Julio|||0000-0002-4735-7838
This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees.